CD8A and neoplasm: Here, we demonstrated that FF-10101, a high-affinity and covalently bound inhibitor of CSF1R, exhibited a strong and sustained antitumor effect by inducing a tumoricidal M1-like macrophage-rich TME, which led to enhanced tumor-specific CD8+ T cell responses.